Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Land

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32Stephanie R Land, Jacek A Kopec, Thomas B Julian, et al.
Molecular Human Reproduction|July 8, 2025
WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Heterologous): heterologous rodent modelsM Louise Hull, Raul Gomez, Warren B Nothnick, et al.
American Journal of Health Promotion : AJHP|October 13, 2020
Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative SurveysJana L Hirschtick, Delvon T Mattingly, Beomyoung Cho, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulvaR Land, J Herod, E Moskovic, et al.
The Journal of Supportive Oncology|September 7, 2012
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32Jacek A Kopec, Linda H Colangelo, Stephanie R Land, et al.
Journal of the National Cancer Institute|March 15, 2011
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCISIrene L Wapnir, James J Dignam, Bernard Fisher, et al.
BMC Public Health|June 24, 2021
A comparison of tobacco product prevalence by different frequency of use thresholds across three US surveysLuz María Sánchez-Romero, Christopher J Cadham, Jana L Hirschtick, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 9, 2021
Patient Perspectives on the Risk-Based NLST Outcomes Tool for Lung Cancer ScreeningMegan C Roberts, Elizabeth L Seaman, William M P Klein, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 24, 2025
Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network TrialsSarah N Price, Stephanie R Land, Kinsey Pebley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphomaSamuel A Jacobs, Steven H Swerdlow, Jeffrey Kant, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32Stephanie R Land, Jacek A Kopec, Thomas B Julian, et al.
Molecular Human Reproduction|July 8, 2025
WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Heterologous): heterologous rodent modelsM Louise Hull, Raul Gomez, Warren B Nothnick, et al.
American Journal of Health Promotion : AJHP|October 13, 2020
Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative SurveysJana L Hirschtick, Delvon T Mattingly, Beomyoung Cho, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Routine computerized tomography scanning, groin ultrasound with or without fine needle aspiration cytology in the surgical management of primary squamous cell carcinoma of the vulvaR Land, J Herod, E Moskovic, et al.
The Journal of Supportive Oncology|September 7, 2012
Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32Jacek A Kopec, Linda H Colangelo, Stephanie R Land, et al.
Journal of the National Cancer Institute|March 15, 2011
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCISIrene L Wapnir, James J Dignam, Bernard Fisher, et al.
BMC Public Health|June 24, 2021
A comparison of tobacco product prevalence by different frequency of use thresholds across three US surveysLuz María Sánchez-Romero, Christopher J Cadham, Jana L Hirschtick, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|March 9, 2021
Patient Perspectives on the Risk-Based NLST Outcomes Tool for Lung Cancer ScreeningMegan C Roberts, Elizabeth L Seaman, William M P Klein, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 24, 2025
Tobacco Assessment in Actively Accruing National Cancer Institute Clinical Trials Network TrialsSarah N Price, Stephanie R Land, Kinsey Pebley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphomaSamuel A Jacobs, Steven H Swerdlow, Jeffrey Kant, et al.
Pageof 15